Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2018 (2018), Article ID 1706982, 11 pages
https://doi.org/10.1155/2018/1706982
Research Article

The Long-Term Outcome Comparison of Different Time-Delayed Kallikrein Treatments in a Mouse Cerebral Ischemic Model

1Department of Neurology, Affiliated Hospital of Nantong University, Jiangsu 226001, China
2Department of Pathophysiology, Medical School of Nantong University, Jiangsu 26001, China
3Geriatric Department, Shanghai Ninth People’s Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 201900, China
4Department of Pathology, Affiliated Hospital of Nantong University, Jiangsu 226001, China
5Department of Neurosurgery, Affiliated Hospital of Nantong University, Jiangsu 226001, China

Correspondence should be addressed to Xing Su; moc.liamg@utngnixus and Jin-hua Gu; moc.liamtoh@ugoalugoal

Received 7 June 2017; Revised 23 September 2017; Accepted 10 October 2017; Published 5 April 2018

Academic Editor: Hailiang Tang

Copyright © 2018 Yaohui Ni et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. A. Donnan, M. Fisher, M. Macleod, and S. M. Davis, “Stroke,” The Lancet, vol. 371, no. 9624, pp. 1612–1623, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. L. Liu, D. Wang, K. S. Wong, and Y. Wang, “Stroke and stroke care in China: huge burden, significant workload, and a national priority,” Stroke, vol. 42, no. 12, pp. 3651–3654, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. E. C. Jauch, J. L. Saver, H. P. Adams Jr. et al., “Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association,” Stroke, vol. 44, no. 3, pp. 870–947, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. K. D. Bhoola, C. D. Figueroa, and K. Worthy, “Bioregulation of kinins: kallikreins, kininogens, and kininases,” Pharmacological Reviews, vol. 44, no. 1, pp. 1–80, 1992. View at Google Scholar
  5. S. Wagner, P. Kalb, M. Lukosava, U. Hilgenfeldt, and M. Schwaninger, “Activation of the tissue kallikrein-kinin system in stroke,” Journal of the Neurological Sciences, vol. 202, no. 1-2, pp. 75-76, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Groger, D. Lebesgue, D. Pruneau et al., “Release of bradykinin and expression of kinin B2 receptors in the brain: role for cell death and brain edema formation after focal cerebral ischemia in mice,” Journal of Cerebral Blood Flow & Metabolism, vol. 25, no. 8, pp. 978–989, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Austinat, S. Braeuninger, J. B. Pesquero et al., “Blockade of bradykinin receptor B1 but not bradykinin receptor B2 provides protection from cerebral infarction and brain edema,” Stroke, vol. 40, no. 1, pp. 285–293, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. C. F. Xia, H. Yin, C. V. Borlongan, L. Chao, and J. Chao, “Kallikrein gene transfer protects against ischemic stroke by promoting glial cell migration and inhibiting apoptosis,” Hypertension, vol. 43, no. 2, pp. 452–459, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. C. F. Xia, R. S. Smith Jr., B. Shen et al., “Postischemic brain injury is exacerbated in mice lacking the kinin B2 receptor,” Hypertension, vol. 47, no. 4, pp. 752–761, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. L. Ling, Q. Hou, S. Xing, J. Yu, Z. Pei, and J. Zeng, “Exogenous kallikrein enhances neurogenesis and angiogenesis in the subventricular zone and the peri-infarction region and improves neurological function after focal cortical infarction in hypertensive rats,” Brain Research, vol. 1206, pp. 89–97, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. D. Y. Ding, C. Z. Lv, M. P. Ding, B. H. Su, and F. Chen, “A multicenter, randomized, double-blinded and placebo-controlled study of acute brain infarction treated by human urinary kallidinogenase,” Chinese Journal of Neurology, vol. 40, no. 5, pp. 306–310, 2007. View at Google Scholar
  12. J. Chen, Y. Li, L. Wang et al., “Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats,” Stroke, vol. 32, no. 4, pp. 1005–1011, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Matsuura, H. Kabuto, H. Makino, and N. Ogawa, “Pole test is a useful method for evaluating the mouse movement disorder caused by striatal dopamine depletion,” Journal of Neuroscience Methods, vol. 73, no. 1, pp. 45–48, 1997. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Tureyen, R. Vemuganti, K. A. Sailor, and R. J. Dempsey, “Infarct volume quantification in mouse focal cerebral ischemia: a comparison of triphenyltetrazolium chloride and cresyl violet staining techniques,” Journal of Neuroscience Methods, vol. 139, no. 2, pp. 203–207, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. C. F. Xia, H. Yin, Y. Y. Yao, C. V. Borlongan, L. Chao, and J. Chao, “Kallikrein protects against ischemic stroke by inhibiting apoptosis and inflammation and promoting angiogenesis and neurogenesis,” Human Gene Therapy, vol. 17, no. 2, pp. 206–219, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. L. Wang, Z. Zhang, Y. Wang, R. Zhang, and M. Chopp, “Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats,” Stroke, vol. 35, no. 7, pp. 1732–7, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. X. Li, K. K. Blizzard, Z. Zeng, A. C. DeVries, P. D. Hurn, and L. D. McCullough, “Chronic behavioral testing after focal ischemia in the mouse: functional recovery and the effects of gender,” Experimental Neurology, vol. 187, no. 1, pp. 94–104, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. A. A. Ardelt, N. Anjum, K. F. Rajneesh, P. Kulesza, and R. C. Koehler, “Estradiol augments peri-infarct cerebral vascular density in experimental stroke,” Experimental Neurology, vol. 206, no. 1, pp. 95–100, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Navarro-Sobrino, A. Rosell, M. Hernandez-Guillamon et al., “A large screening of angiogenesis biomarkers and their association with neurological outcome after ischemic stroke,” Atherosclerosis, vol. 216, no. 1, pp. 205–211, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Emanueli, A. Minasi, A. Zacheo et al., “Local delivery of human tissue kallikrein gene accelerates spontaneous angiogenesis in mouse model of hindlimb ischemia,” Circulation, vol. 103, no. 1, pp. 125–132, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Yoshida, J. J. Zhang, L. Chao, and J. Chao, “Kallikrein gene delivery attenuates myocardial infarction and apoptosis after myocardial ischemia and reperfusion,” Hypertension, vol. 35, 1 Part 1, pp. 25–31, 2000. View at Publisher · View at Google Scholar
  22. R. S. Smith Jr., L. Gao, L. Chao, and J. Chao, “Tissue kallikrein and kinin infusion promotes neovascularization in limb ischemia,” Biological Chemistry, vol. 389, no. 6, pp. 725–730, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Agata, L. Chao, and J. Chao, “Kallikrein gene delivery improves cardiac reserve and attenuates remodeling after myocardial infarction,” Hypertension, vol. 40, no. 5, pp. 653–659, 2002. View at Publisher · View at Google Scholar · View at Scopus
  24. Y. Y. Yao, H. Yin, B. Shen et al., “Tissue kallikrein promotes neovascularization and improves cardiac function by the Akt-glycogen synthase kinase-3β pathway,” Cardiovascular Research, vol. 80, no. 3, pp. 354–364, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. B. H. Jiang, J. Z. Zheng, M. Aoki, and P. K. Vogt, “Phosphatidylinositol 3-kinase signaling mediates angiogenesis and expression of vascular endothelial growth factor in endothelial cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 4, pp. 1749–1753, 2000. View at Publisher · View at Google Scholar · View at Scopus
  26. K. Maruyama, Y. Mori, S. Murasawa et al., “Interleukin-1βupregulates cardiac expression of vascular endothelial growth factor and its receptor KDR/flk-1 via activation of protein tyrosine kinases,” Journal of Molecular and Cellular Cardiology, vol. 31, no. 3, pp. 607–617, 1999. View at Publisher · View at Google Scholar · View at Scopus